Guillermo Morales

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity”.

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

Cell Discovery(2020)10.1038/s41421-020-0181-z

N/A

0DataRank · unranked

15 citations

Kendra R. Vann, Shweta Joshi, Guillermo Morales, Francisco M. De La Vega, Alok Singh +5 more

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets

Scientific Reports(2020)10.1038/s41598-020-68964-6

N/A

0DataRank · unranked

12 citations

Dhananjaya Pal, Guillermo Morales, Adam M. Burgoyne, Donald L. Durden, Tatiana G. Kutateladze +1 more

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

iScience(2021)10.1016/j.isci.2021.102931

N/A

0DataRank · unranked

14 citations

Kendra R. Vann, Shweta Joshi, Namood-e Sahar, Guillermo Morales, Dalia El‐Gamal +3 more

Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.02.433604

N/A

0DataRank · unranked

13 citations

Kabita Pandey, Michellie Thurman, Kishore B. Challagundala, Kendra R. Vann, Tatiana G. Kutateladze +4 more

LC–MS/MS method for the quantitation of a dual PI3K/BRD4 inhibitor SF2523 in mouse plasma: Application to plasma protein binding and metabolism studies

Biomedical Chromatography(2023)10.1002/bmc.5643

N/A

0DataRank · unranked

3 citations

Yashpal S. Chhonker, Guillermo Morales, Maddeboina Krishnaiah, Dhananjaya Pal, Donald L. Durden +2 more